查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629237

脂多醣免疫分析市場，按類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Lipopolysaccharides Immunoassay Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，脂多醣免疫分析市場規模為19.9409億美元，2024年至2032年複合年成長率為4.30%。

脂多醣免疫分析市場-市場動態

藥品和生物製劑中內毒素檢測需求的不斷成長以及傳染病的流行預計將推動市場需求

對生物製藥（特別是生物製品和疫苗）不斷成長的需求推動了對有效內毒素檢測的需求，以確保這些產品的安全和質量，從而促進市場成長。脂多醣是一種強效內毒素，可引起人類嚴重的免疫反應，如發燒、感染性休克和器官衰竭。因此，包括 FDA 和 EMA 在內的監管機構要求對注射藥物、醫療器材和疫苗進行嚴格的內毒素檢測，以滿足安全標準。這增加了這些產品的品質控制和驗證過程中對 LPS 免疫測定的需求。政府法規和國際標準在塑造 LPS 免疫分析市場方面發揮著至關重要的作用。包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 和世界衛生組織 (WHO) 在內的多個衛生當局都制定了嚴格的內毒素檢測指南，以確保產品安全。

包括細菌感染在內的傳染病的增加以及最近爆發的 COVID-19 等流行病，凸顯了快速、準確的內毒素檢測的重要性。脂多醣存在於革蘭氏陰性菌的外膜中，與免疫系統活化和發炎反應有關。因此，有效的 LPS 免疫測定對於診斷細菌感染和監測發炎性疾病至關重要。此類疾病發病率的不斷上升推動了對靈敏、快速檢測方法的需求，以監測和管理疫情。此外，持續關注免疫學、傳染病和內毒素檢測技術的研發（R＆D）也有助於市場的成長。

脂多醣免疫分析市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.30% 左右的複合年成長率成長

根據類型細分，由於傳染病藥物和開發以及疫苗的需求不斷增加，預計試劑盒和試劑細分市場將在 2023 年顯示最大的市場佔有率。

根據應用細分，由於新藥和新發現的不斷增加，研發領域成為 2023 年的領先應用。

根據最終用戶細分，由於醫院設施對套件和儀器的需求很高，醫院細分市場將在 2023 年成為領先的最終用戶細分市場。

按地區分類，由於對醫院基礎設施的投資，北美將成為 2023 年的主要收入來源。

脂多醣免疫分析市場-細分分析：

全球脂多醣免疫分析市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為三類：試劑盒和試劑、儀器和消耗品。試劑盒和試劑細分市場佔據主導地位。藥品需求的成長和免疫分​​析技術的進步預計將推動該領域的成長。

市場依應用分為三類：臨床試驗、研發等。由於免疫學內毒素檢測技術的投資不斷增加，補充了市場的成長，預計研發領域將在預測期內佔據主導地位。

根據最終用戶，市場分為三類：醫院、診所和其他。醫院領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。醫院擴大採用先進的免疫分析方法，推動了細分市場的需求。

脂多醣免疫分析市場-地理洞察

在全球範圍內，脂多醣免疫分析市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。北美在 LPS 免疫分析市場佔據主導地位，主要是由於其完善的醫療保健系統、廣泛的製藥和生物技術行業以及嚴格的監管標準。美國在該地區佔有最大佔有率，在品質控制中大量採用免疫測定法。由於其強勁的製藥業以及遵守嚴格的歐盟藥品和設備安全法規，歐洲佔第二大市場佔有率。歐洲藥品管理局 (EMA) 執行嚴格的內毒素檢測標準，推動了市場的發展。在醫療基礎設施投資增加以及生物製品和疫苗需求不斷成長的推動下，亞太地區預計將出現最快的成長。

脂多醣免疫分析市場-競爭格局：

在診斷技術的進步以及臨床和研究應用需求不斷成長的推動下，脂多醣免疫分析市場正在經歷顯著的競爭動態。市場主要參與者，如 BioChek (BIOTECON Diagnostics)、AdVnt Biotechnologies、Thermo Fisher Scientific 等。例如，即時檢測解決方案因其在診斷心血管等疾病方面的應用而受到關注。多家公司正在與研究機構和醫療保健提供者合作，以提高檢測的特異性和準確性。

最新進展：

2023 年，賽默飛世爾科技推出了先進的免疫測定試劑盒，提高了 LPS 檢測的敏感度。

2023 年，Response Biomedical 在研發方面投入了大量資金，以提高用於快速床邊診斷的側流免疫分析 (LFA) 的性能。

目錄

第 1 章：脂多醣免疫分析市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的脂多醣免疫分析市場片段
    • 脂多醣免疫分析市場片段（依應用）
    • 最終用戶的脂多醣免疫分析市場片段
    • 按國家/地區分類的脂多醣免疫分析市場片段
    • 按地區分類的脂多醣免疫分析市場片段
  • 競爭洞察

第 3 章：脂多醣免疫分析主要市場趨勢

  • 脂多醣免疫分析市場促進因素
    • 市場促進因素的影響分析
  • 脂多醣免疫分析市場限制
    • 市場限制影響分析
  • 脂多醣免疫分析市場機會
  • 脂多醣免疫分析市場未來趨勢

第 4 章：脂多醣免疫分析產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：脂多醣免疫分析市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：脂多醣免疫測定市場格局

  • 脂多醣免疫分析市佔率分析，2024 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：脂多醣免疫分析市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 試劑盒和試劑
    • 儀器儀表
    • 耗材

第 8 章：脂多醣免疫分析市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 臨床試驗
    • 研究與開發
    • 其他

第 9 章：脂多醣免疫分析市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：脂多醣免疫分析市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美脂多醣免疫分析主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲脂多醣免疫分析主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區脂多醣免疫分析主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲脂多醣免疫分析主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲脂多醣免疫分析主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-脂多醣免疫分析產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Bio-Techne
    • BioChek (BIOTECON Diagnostics)
    • AdVnt Biotechnologies
    • Response Biomedical
    • New Horizons Diagnostic Corporation
    • Merck KGaA
    • Lonza Group AG
    • Abcam plc
    • Creative Diagnostics
    • GenScript Biotech Corporation
    • Enzo Life Sciences
    • MyBioSource, Inc.
    • PerkinElmer, Inc.
    • R&D Systems
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4369

REPORT HIGHLIGHT

Lipopolysaccharides Immunoassay Market size was valued at USD 1,994.09 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.

A Lipopolysaccharides (LPS) Immunoassay is a laboratory technique used to detect and quantify lipopolysaccharides, which are large molecules found in the outer membrane of Gram-negative bacteria. LPS are significant because they play a key role in triggering the immune response in humans and animals and are often considered endotoxins.

Lipopolysaccharides Immunoassay Market- Market Dynamics

Rising demand for endotoxin testing in pharmaceuticals and biologics and prevalence of infectious diseases are expected to propel market demand

The growing demand for biopharmaceuticals, particularly biologics and vaccines, has driven the need for effective endotoxin testing to ensure the safety and quality of these products, boosting market growth. Lipopolysaccharides are potent endotoxins that can induce severe immune responses in humans, such as fever, septic shock, and organ failure. Consequently, regulatory bodies, including the FDA and EMA, require rigorous endotoxin testing of injectable drugs, medical devices, and vaccines to meet safety standards. This has bolstered the demand for LPS immunoassays in the quality control and validation processes of these products. Government regulations and international standards play a critical role in shaping the LPS immunoassay market. Various health authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), have stringent guidelines for endotoxin testing to ensure product safety.

The increase in infectious diseases, including bacterial infections and the recent epidemic outbreaks such as COVID-19, has highlighted the importance of rapid and accurate endotoxin detection. Lipopolysaccharides, found in the outer membrane of Gram-negative bacteria, are linked to immune system activation and inflammatory responses. As a result, effective LPS immunoassays are crucial for diagnosing bacterial infections and monitoring inflammatory diseases. The growing incidence of such diseases drives the demand for sensitive and rapid detection methods to monitor and manage outbreaks. Also, a continuous focus on research and development (R&D) in immunology, infectious diseases, and endotoxin detection technologies contributes to the market's growth.

Lipopolysaccharides Immunoassay Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)

Based on Type segmentation, kits & reagents segment was predicted to show maximum market share in the year 2023, owing to increasing demand from drugs & developments and vaccines for infectious diseases.

Based on Application segmentation, research & developments segment was the leading application in 2023, due to rising novel drugs & discoveries.

Based on End User segmentation, hospital segment was the leading End User segment in 2023, due to high demand for kits and instruments in hospital facilities.

On the basis of region, North America was the leading revenue generator in 2023, owing to investments in hospital infrastructure.

Lipopolysaccharides Immunoassay Market- Segmentation Analysis:

The Global Lipopolysaccharides Immunoassay Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into three categories based on Type: kits & reagents, instruments, and consumables. The kits & reagents segment dominates the market. The growing demand from pharmaceuticals and advancement in immunoassay technologies is expected to boost segment growth.

The market is divided into three categories based on the Application: clinical trials, research & development, and others. The research & development segment is expected to dominate over the forecast period, owing to the rising investment in immunology endotoxin detection technologies supplementing market growth.

The market is divided into three categories based on End User: hospital, clinics, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing adoption of advanced immunoassay methods at hospitals is boosting segment demand.

Lipopolysaccharides Immunoassay Market- Geographical Insights

Worldwide, the Lipopolysaccharides Immunoassay market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the LPS immunoassay market, primarily due to its well-established healthcare system, extensive pharmaceutical and biotechnology industries, and stringent regulatory standards. The U.S. contributes the largest share in this region, with significant adoption of immunoassays in quality control. Europe holds the second-largest market share due to its robust pharmaceutical sector and adherence to stringent EU regulations for drug and device safety. The European Medicines Agency (EMA) enforces rigorous standards for endotoxin testing, propelling the market. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing investment in healthcare infrastructure and rising demand for biologics and vaccines.

Lipopolysaccharides Immunoassay Market- Competitive Landscape:

The Lipopolysaccharides Immunoassay market is experiencing significant competitive dynamics, driven by advancements in diagnostic technologies and increasing demand across clinical and research applications. Key players in the market, such as BioChek (BIOTECON Diagnostics), AdVnt Biotechnologies, Thermo Fisher Scientific, etc. Several companies have launched or enhanced their offerings, focusing on rapid diagnostic kits and advanced immunoassay technologies such as ELISA and CLIA. For instance, point-of-care testing solutions are gaining traction due to their application in diagnosing diseases like cardiovascular. Several firms are partnering with research institutions and healthcare providers to enhance assay specificity and accuracy.

Recent Developments:

In 2023, Thermo Fisher Scientific has introduced advanced immunoassay kits with enhanced sensitivity for LPS detection.

In 2023, Response Biomedical invested a significant share in R&D to improve the performance of lateral flow immunoassays (LFAs) for rapid bedside diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Bio-Techne
  • BioChek (BIOTECON Diagnostics)
  • AdVnt Biotechnologies
  • Response Biomedical
  • New Horizons Diagnostic Corporation
  • Merck KGaA
  • Lonza Group AG
  • Abcam plc
  • Creative Diagnostics
  • GenScript Biotech Corporation
  • Enzo Life Sciences
  • MyBioSource, Inc.
  • PerkinElmer, Inc.
  • R&D Systems
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Kits & reagents
  • Instruments
  • Consumables

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical Trials
  • Research & Development
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lipopolysaccharides Immunoassay Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lipopolysaccharides Immunoassay Market Snippet by Type
    • 2.1.2. Lipopolysaccharides Immunoassay Market Snippet by Application
    • 2.1.3. Lipopolysaccharides Immunoassay Market Snippet by End User
    • 2.1.4. Lipopolysaccharides Immunoassay Market Snippet by Country
    • 2.1.5. Lipopolysaccharides Immunoassay Market Snippet by Region
  • 2.2. Competitive Insights

3. Lipopolysaccharides Immunoassay Key Market Trends

  • 3.1. Lipopolysaccharides Immunoassay Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lipopolysaccharides Immunoassay Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lipopolysaccharides Immunoassay Market Opportunities
  • 3.4. Lipopolysaccharides Immunoassay Market Future Trends

4. Lipopolysaccharides Immunoassay Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lipopolysaccharides Immunoassay Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Lipopolysaccharides Immunoassay Market Landscape

  • 6.1. Lipopolysaccharides Immunoassay Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lipopolysaccharides Immunoassay Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Kits & reagents
    • 7.1.3. Instruments
    • 7.1.4. Consumables

8. Lipopolysaccharides Immunoassay Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical Trials
    • 8.1.3. Research & Development
    • 8.1.4. Others

9. Lipopolysaccharides Immunoassay Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Lipopolysaccharides Immunoassay Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lipopolysaccharides Immunoassay Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lipopolysaccharides Immunoassay Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lipopolysaccharides Immunoassay Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Lipopolysaccharides Immunoassay Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Lipopolysaccharides Immunoassay Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Lipopolysaccharides Immunoassay Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Bio-Techne
    • 11.2.3. BioChek (BIOTECON Diagnostics)
    • 11.2.4. AdVnt Biotechnologies
    • 11.2.5. Response Biomedical
    • 11.2.6. New Horizons Diagnostic Corporation
    • 11.2.7. Merck KGaA
    • 11.2.8. Lonza Group AG
    • 11.2.9. Abcam plc
    • 11.2.10. Creative Diagnostics
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Enzo Life Sciences
    • 11.2.13. MyBioSource, Inc.
    • 11.2.14. PerkinElmer, Inc.
    • 11.2.15. R&D Systems
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us